Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppression Disorders”

499 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 499 results

Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Early research (Phase 1)Study completedNCT00684008
What this trial is testing

Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

Who this might be right for
AMLCMLMDS
Cytheris, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00258713
What this trial is testing

A 36-Week Extension to Protocol ISA04-03

Who this might be right for
Psoriasis
Aurinia Pharmaceuticals Inc. 309
Testing effectiveness (Phase 2)UnknownNCT05739045
What this trial is testing

Nivolumab Combined With SOX Used in the Perioperative Treatment

Who this might be right for
Immune SuppressionGastric Cancer
Xiangdong Cheng 46
Testing effectiveness (Phase 2)Study completedNCT00306098
What this trial is testing

Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression

Who this might be right for
Diabetes Mellitus, Type I
Rodolfo Alejandro 26
Testing effectiveness (Phase 2)Study completedNCT00001832
What this trial is testing

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 170
Not applicableLooking for participantsNCT04800393
What this trial is testing

The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.

Who this might be right for
AnesthesiaBreast Cancer
Moscow Clinical Scientific Center 130
Large-scale testing (Phase 3)Ended earlyNCT01408836
What this trial is testing

Plasma Exchange for Renal Vasculitis

Who this might be right for
Wegener's GranulomatosisMicroscopic Polyangiitis
Cambridge University Hospitals NHS Foundation Trust 150
Testing effectiveness (Phase 2)UnknownNCT02196467
What this trial is testing

Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients

Who this might be right for
Duchenne Muscular Dystrophy
CHU de Quebec-Universite Laval 10
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Looking for participantsNCT05126849
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

Who this might be right for
Refractory Idiopathic Aplastic AnemiaHaploidentical Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 31
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578558
What this trial is testing

NAI for Sepsis With Persistent Lymphopenia

Who this might be right for
SepsisSeptic ShockLymphopenia+2 more
ImmunityBio, Inc. 50
Testing effectiveness (Phase 2)UnknownNCT01423708
What this trial is testing

Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

Who this might be right for
Liver FailureLiver DiseasesLiver Cirrhosis+1 more
Azienda Ospedaliera di Padova 117
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Post-approval studies (Phase 4)Study completedNCT00275535
What this trial is testing

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

Who this might be right for
Kidney Diseases
Mayo Clinic 165
Post-approval studies (Phase 4)Study completedNCT01964014
What this trial is testing

Once-a-day Immunosuppression(CISECON_a_day)

Who this might be right for
Chronic Renal Disease
Ajou University School of Medicine 160
Not applicableNot Yet RecruitingNCT06024226
What this trial is testing

Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Who this might be right for
Lung NeoplasmsMyeloid-Derived Suppressor CellsImmunosuppression
University Hospital, Bordeaux 10
Large-scale testing (Phase 3)Study completedNCT00611663
What this trial is testing

Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Assistance Publique - Hôpitaux de Paris 47
Early research (Phase 1)WithdrawnNCT03047200
What this trial is testing

Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

Who this might be right for
Islet Cell TransplantationType 1 Diabetes
Baylor Research Institute
Next Page